| __timestamp | Madrigal Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 5496000 |
| Thursday, January 1, 2015 | 13392000 | 9786000 |
| Friday, January 1, 2016 | 9290000 | 6792000 |
| Sunday, January 1, 2017 | 7672000 | 7313000 |
| Monday, January 1, 2018 | 15293000 | 8382000 |
| Tuesday, January 1, 2019 | 22648000 | 10803000 |
| Wednesday, January 1, 2020 | 21864000 | 12944000 |
| Friday, January 1, 2021 | 37318000 | 21967000 |
| Saturday, January 1, 2022 | 48130000 | 32810000 |
| Sunday, January 1, 2023 | 108146000 | 46542000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A expenses of Madrigal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. from 2014 to 2023. Over this period, Madrigal Pharmaceuticals saw a staggering increase of over 580% in their SG&A expenses, peaking in 2023. In contrast, Xenon Pharmaceuticals experienced a more modest rise of approximately 750%, reflecting a steady growth strategy.
This data provides a fascinating glimpse into how these companies allocate resources, offering insights into their strategic priorities and market positioning.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Madrigal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or MannKind Corporation
Operational Costs Compared: SG&A Analysis of Madrigal Pharmaceuticals, Inc. and Xencor, Inc.
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.